Carregant...

Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine Carcinoma

OBJECTIVES: A platinum/etoposide doublet is standard 1st-line therapy for poorly-differentiated neuroendocrine carcinoma (PD NEC), however evidence to guide treatment beyond 1st-line regimens is lacking. This study aimed to evaluate the efficacy of 2nd-line regimens in PD NEC. METHODS: We performed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pancreas
Autors principals: McGarrah, Patrick W., Leventakos, Konstantinos, Hobday, Timothy J., Molina, Julian R., Finnes, Heidi D., Westin, Gustavo F., Halfdanarson, Thorvardur R.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158760/
https://ncbi.nlm.nih.gov/pubmed/32282766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000001529
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!